CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Mitsubishi Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
Mar 28, 2018Novel Therapeutic Agent For Amyotrophic Lateral Sclerosis (Als) Or Disease Attributable To Als1

Top competitors of Mitsubishi Pharma

Top competitors of Mitsubishi Pharma based on patent oppositions.